Renaissance Pharma Ltd.
1 clinical trials · Sponsor
◉ Watch Renaissance Pharma Ltd.
| Record | Firm | Date |
|---|---|---|
| A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients (NCT07549321) | Renaissance Pharma Ltd. | 2026-03-30 |
Track Renaissance Pharma Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.